Press Releases
Press Release filters
Sign up to receive updates from mdxhealth
Click the button below to fill in your contact information and receive updates from mdxhealth.
Keynote Presentation Reports Lack of Knowledge on Clinical Advances Achieved by the New Generation of Biomarker Tests for Prostate Cancer
Independent Survey Results Presented at the 5th Global Congress on Prostate Cancer (PROSCA) Indicate Untapped Market Potential for
MDxHealth Presents Three SelectMDx Studies at 5th Global Congress on Prostate Cancer
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION
MDxHealth and Queensland University of Technology Collaborate on Oral Cancer Liquid Biopsy Test
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION
MDxHealth’s New Share Capital Amount and New Number of Shares
Press release / Regulated information IRVINE, CA, and HERSTAL, BELGIUM – 19.30 p.m. CEST, May 5, 2017 – MDxHealth SA (the “
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM – 07:00 CEST, May 5, 2017 – MDxHealth
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM – 07:00 CEST, May 2, 2017 – MDxHealth
MDxHealth and Exact Sciences Sign Collaboration Agreement
Exact Sciences also to acquire biomarker and technology patents NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVIN
New Study Shows MDxHealth’s SelectMDx Test is Cost-Effective for Biopsy Selection
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM – 07:00 CEST, April 10, 2017 – MDxHea
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM – 07:00 CET, April 4, 2017 – MDxHealt
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM – March 21, 2017 – MDxHealth SA (Euro
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM – March 8, 2017 – MDxHealth SA (Euron
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM – February 23, 2017 – MDxHealth SA (E
MDxHealth Reports Financial Year 2016 Results
NEWS RELEASE REGULATED INFORMATION INSIDE INFORMATION Record revenue of $30 million, up 70% from 2015Total test volume up
MDxHealth Notice of Financial Year 2016 Results
Conference call for analysts and investors to be held on 23 February 2017 at 15:00 CET IRVINE, CA, and HERSTAL, BELGIUM – Februar
MDxHealth Awarded US Department of Veterans Affairs Contract for ConfirmMDx Testing
NEWS RELEASE REGULATED INFORMATION INSIDE INFORMATION
MDxHealth Announces Horizon Blue Cross Blue Shield of New Jersey Issues Positive Coverage Policy on ConfirmMDx
NEWS RELEASE REGULATED INFORMATION INSIDE INF
MDxHealth Announces Preliminary Update on 2016 Results and Appointment of CFO
On track to meet full-year earnings guidance based on strong ConfirmMDx growthJean-Marc Roelandt appointed Chief Financial Officer
MDxHealth reçoit la certification ISO 13485:2016 pour son laboratoire aux Pays-Bas
Une étape-clé dans la stratégie de diagnostic in vitro (DIV) de MDxHealth en Europe La certification permet à MDxHealth de
Nouveau montant du capital social et nouveau nombre d’actions de MDxHealth
IRVINE, CA, et HERSTAL (BELGIQUE) – Le 15 novembre 2016 – 7:00 AM CET – MDxHealth SA (la “Société”) (Euronext Brussels: MDXH) a
MDxHealth fera une présentation en novembre 2016 lors de conférences destinées à des investisseurs
IRVINE, CA, et HERSTAL, BELGIQUE – Le 14 novembre 2016 – MDxHealth SA (Euronext: MDXH.BR), a annoncé aujourd’hui que le Dr Jan Gr
